Abstract
BackgroundRecently due to application of genetically engineered biologic drugs (GEBD) prognosis for juvenile idiopathic arthritis (JIA) has significantly improved. 558 children with JIA are under monitoring in Chelyabinsk region. If...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
